Authors: TATTON WG CHALMERSREDMAN RME

Citation: Wg. Tatton et Rme. Chalmersredman, MITOCHONDRIA IN NEURODEGENERATIVE APOPTOSIS - AN OPPORTUNITY FOR THERAPY, Annals of neurology, 44(3), 1998, pp. 134-141

Authors: WADIA JS CHALMERSREDMAN RME JU WJH CARLILE GW PHILLIPS JL FRASER AD TATTON WG

Citation: Js. Wadia et al., MITOCHONDRIAL-MEMBRANE POTENTIAL AND NUCLEAR-CHANGES IN APOPTOSIS CAUSED BY SERUM AND NERVE GROWTH-FACTOR WITHDRAWAL - TIME-COURSE AND MODIFICATION BY (-)-DEPRENYL, The Journal of neuroscience, 18(3), 1998, pp. 932-947

Authors: CHALMERSREDMAN RME PRIESTLEY T KEMP JA FINE A

Citation: Rme. Chalmersredman et al., IN-VITRO PROPAGATION AND INDUCIBLE DIFFERENTIATION OF MULTIPOTENTIAL PROGENITOR CELLS FROM HUMAN FETAL BRAIN, Neuroscience, 76(4), 1997, pp. 1121-1128

Authors: TATTON WG CHALMERSREDMAN RME JU WYH WADIA J TATTON NA

Citation: Wg. Tatton et al., APOPTOSIS IN NEURODEGENERATIVE DISORDERS - POTENTIAL FOR THERAPY BY MODIFYING GENE-TRANSCRIPTION, Journal of neural transmission. Supplementum, (49), 1997, pp. 245-268

Authors: TATTON WG WADIA JS JU WYH CHALMERSREDMAN RME TATTON NA

Citation: Wg. Tatton et al., (-)-DEPRENYL REDUCES NEURONAL APOPTOSIS AND FACILITATES NEURONAL OUTGROWTH BY ALTERING PROTEIN-SYNTHESIS WITHOUT INHIBITING MONOAMINE-OXIDASE, Journal of neural transmission. Supplementum, (48), 1996, pp. 45-59

Authors: TATTON WG CHALMERSREDMAN RME

Citation: Wg. Tatton et Rme. Chalmersredman, MODULATION OF GENE-EXPRESSION RATHER THAN MONOAMINE-OXIDASE INHIBITION - (-)-DEPRENYL-RELATED COMPOUNDS IN CONTROLLING NEURODEGENERATION, Neurology, 47(6), 1996, pp. 171-183